SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 10.20 |
| Enterprise Value ($M) | 2.82 |
| Book Value ($M) | 6.00 |
| Book Value / Share | 0.59 |
| Price / Book | 1.70 |
| NCAV ($M) | 5.39 |
| NCAV / Share | 0.53 |
| Price / NCAV | 1.89 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.44 |
| Return on Assets (ROA) | -0.84 |
| Return on Equity (ROE) | -0.97 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.42 |
| Current Ratio | 3.42 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.63 |
| Assets | 8.24 |
| Liabilities | 2.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Meckler Jeffrey A | 7.30 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 936 | 35,499 | 2.64 | |
| 31,185 | 99,993 | 31.19 | |
| 2,176 | 9,027 | 24.11 | |
| 4,817 | 11,236 | 42.87 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IMNM – Immunome, Inc. | IMNN – Imunon, Inc. |
| IMTX – Immatics N.V. | INKT – MiNK Therapeutics, Inc. |
| INM – InMed Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io